Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil plus finasteride for LUTS and prostatic enlargement due to BPH
2010-020604-29Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Tadalafil + finasteride with Placebo + finasteride (2 arms). Primary endpoint: Change in total International Prostate Symptom Score. Started Jul 2010; status: completed.
02
Drugs
tadalafilfinasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2010-020604-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020604-29.